Blueblood Ventures Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 13/11/2026 ,inter alia, to consider and approve Inter-alia, the Unaudited Standalone Financial Results for the Second Quarter and half year ended 30th September, 2026.

BLUEBLOOD VENTURES LIMITED CIN: L70102DL2007PLC159680 November, 2»d, 2026 The Secretary BSE Limited Phizore Jeejeebhoy Tower, 27% Floor, Dalal Street, Mumbai-400001 Dear Sir, Sub: Notice of Board Meeting- Regulation-29 of the Securities and Exchange Board of India (Listing Obligations and Disclosures Requirements) Regulations, 2015 Notice is hereby given pursuant to Regulation 29 of Securities and Exchange Board of India (Listing Obligations and Disclosures Requirements) Regulations, 2015 that a meeting of board of Directors of the Company will be held on Friday, 13% Day of November, 2026 at M-55, Third Floor Greater Kailash-II New Delhi-110048 IN to consider and approve inter-alia, the Unaudited Standalone Financial Results for the Second Quarter and half year ended 30th September, 2026. Further, in continuation to our earlier intimation in compliance of the provisions of the SEBI (Prohibition ofI nsider Trading) Regulations, 2015 and the Company's "Code of Internal Procedures and Conduct for Regulating, Monitoring and Reporting of Trading in Securities by Designated Persons", the Trading Window for dealing in the securities of the Company for all the Designated Persons including Insiders, had already been closed w.e.f. September 30, 2026, and the same shall re-open on November 15t,2026. This is for your information and records. Thanking You, Yours Faithfully For Blueblood Ventures Limited Suresh Bohra (Managing Director) DIN: 00093343 OFFICE: M-55, 3RD FLOOR, M BLOCK MARKET, GREATER KAILASH II,New Delhi- 110048. PH. 011-41611745, EMAIL ID: Blueblood@blackfoxindia.com Website: www.bluebloodventure.com